Showing results (101-110 of 124) with videos related to
Sort By:
Pageof 13
Annals of the Rheumatic Diseases|January 22, 2021
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohortsAngel Ys Wong, Brian MacKenna, Caroline E Morton, et al.Journal of Hematology & Oncology|October 20, 2021
Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study, Angel Y S Wong, Laurie A Tomlinson, et al.The Lancet. Respiratory Medicine|September 27, 2020
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platformAnna Schultze, Alex J Walker, Brian MacKenna, et al.Plos Medicine|January 25, 2022
Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platformKrishnan Bhaskaran, Christopher T Rentsch, George Hickman, et al.The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 9, 2021
OpenSAFELY NHS Service Restoration Observatory 1: primary care clinical activity in England during the first wave of COVID-19Helen J Curtis, Brian MacKenna, Richard Croker, et al.The Lancet. Rheumatology|December 22, 2020
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platformChristopher T Rentsch, Nicholas J DeVito, Brian MacKenna, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 19, 2021
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 FebruaryDaniel J Grint, Kevin Wing, Elizabeth Williamson, et al.BMJ (Clinical Research Ed.)|November 17, 2022
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platformBang Zheng, Amelia C A Green, John Tazare, et al.BMJ (Clinical Research Ed.)|July 15, 2021
Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platformElizabeth J Williamson, Helen I McDonald, Krishnan Bhaskaran, et al.Vaccine|June 17, 2022
Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platformJemma L Walker, Anna Schultze, John Tazare, et al.Pageof 13